Loading…
Galt Pharmaceuticals LLC, a drug manufacturer, received a Warning Letter from the FDA on September 13, 2019, indicating significant regulatory compliance issues. While the specific violations are not detailed in the available metadata, the letter indicates problems serious enough to warrant formal FDA enforcement action in the pharmaceutical manufacturing sector. Without access to the full letter text, the precise nature of the violations and the specific issuing FDA office cannot be determined from this summary information alone.